NEW YORK (GenomeWeb News) – The Center for Human Genetics of Boston University and the Center for Human Genetics Inc., will stop offering testing services that are covered by patents licensed to Athena Diagnostics, Boston University said today.
 
Athena Diagnostics, a subsidiary of Thermo Fisher Scientific, focuses on offering tests for neurological diseases, such as Alzheimer’s disease and neuromuscular diseases, that it licenses from universities.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.